DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 142 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | -20.0% | 494 | 0.0% | 0.00% | -25.0% |
| Q4 2018 | $5,000 | -16.7% | 494 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $6,000 | -25.0% | 494 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $8,000 | -20.0% | 494 | 0.0% | 0.01% | -22.2% |
| Q1 2018 | $10,000 | +11.1% | 494 | 0.0% | 0.01% | +12.5% |
| Q4 2017 | $9,000 | – | 494 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |